Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Opnext was a leading designer and manufacturer of high-performance optical components and modules, originally established as a spin-off from Hitachi's Fiber Optics Division. While primarily known for its contributions to the optical networking and data communications industries, the company was a significant supplier to the life sciences and healthcare sectors. Opnext provided high-reliability laser diodes and optical modules used in critical medical applications, including DNA sequencing, flow cytometry, and medical imaging. The company's technology was integral to the development of advanced diagnostic and research instrumentation. Opnext was acquired by Oclaro in 2012, which subsequently became part of Lumentum.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Opnext.